<?xml version='1.0' encoding='UTF-8' ?>
<Trials_downloaded_from_ICTRP>

    
  <Trial><Export_date>03/02/2024 23:52:17</Export_date>
    <Internal_Number>13519349
    </Internal_Number>
    <TrialID>NCT06070233
    </TrialID>
    <Last_Refreshed_on>6 November 2023
    </Last_Refreshed_on>
    <Public_title>Radiosurgery Treatment for Spasticity Associated With Stroke, SCI &amp; Cerebral Palsy
    </Public_title>
    <Scientific_title>A Randomized, Sham Controlled Trial of Dorsal Root Rhizotomy Stereotactic Radiosurgery Versus Standard of Care for Spasticity Associated With Stroke, Spinal Cord Injury &amp; Cerebral Palsy
    </Scientific_title>
    <Acronym>SPASM
    </Acronym>
    <Primary_sponsor>Ohio State University
    </Primary_sponsor>
    <Retrospective_flag>Yes
    </Retrospective_flag>
    <Date_registration3>20230930
    </Date_registration3>
    <Date_registration>30/09/2023
    </Date_registration>
    <Source_Register>ClinicalTrials.gov
    </Source_Register>
    <web_address>https://clinicaltrials.gov/ct2/show/NCT06070233
    </web_address>
    <Recruitment_Status>Recruiting
    </Recruitment_Status>
    <other_records>No
    </other_records>
    <Inclusion_agemin>16 Years
    </Inclusion_agemin>
    <Inclusion_agemax>N/A
    </Inclusion_agemax>
    <Inclusion_gender>All
    </Inclusion_gender>
    <Date_enrollement>October 12, 2023
    </Date_enrollement>
    <Target_size>22
    </Target_size>
    <Study_type>Interventional
    </Study_type>
    <Study_design>Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: Double (Participant, Outcomes Assessor). 
    </Study_design>
    <Phase>N/A
    </Phase>
    <Countries>United States;Italy;United States
    </Countries>
    <Contact_Firstname> ; 
    </Contact_Firstname>
    <Contact_Lastname>Evan Thomas, MD/PhD;Destiny West, BS
    </Contact_Lastname>
    <Contact_Email>;Destiny.West@osumc.edu
    </Contact_Email>
    <Contact_Tel>;(614) 366-7822
    </Contact_Tel>
    <Contact_Affiliation>The Ohio State University Wexner Medical Center;
    </Contact_Affiliation>
    <Inclusion_Criteria>&#x0D;&lt;br&gt;        Inclusion Criteria:&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Chronic spasticity refractory to medical management or in a patient who cannot receive&#x0D;&lt;br&gt;             appropriate medical management mediated by one or more spinal nerve roots&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Age &gt; 16 (if under 18, patients parents must sign consent).&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;        Exclusion Criteria:&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Inability to lie supine for simulation &amp; treatment&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Inability to visualize the target nerve on either CT or MRI imaging&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Patients with confirmed pregnancy (all women of child-bearing age with intact uterus &amp;&#x0D;&lt;br&gt;             ovaries will be required to undergo a pregnancy test prior to simulation)&#x0D;&lt;br&gt;      
    </Inclusion_Criteria>
    <Condition>Spasticity as Sequela of Stroke;Spastic Cerebral Palsy;Spasticity, Muscle
    </Condition>
    <Intervention>Radiation: stereotactic radiosurgery (SRS) dorsal root rhizotomy radiomodulation;Other: Sham
    </Intervention>
    <Primary_outcome>Change in Modified Ashworth Scale
    </Primary_outcome>
    <Secondary_outcome>Change in spasticity-related quality of life (SQoL-6D)
    </Secondary_outcome>
    <Secondary_ID>2022H0425
    </Secondary_ID>
    <Source_Support>Please refer to primary and secondary sponsors
    </Source_Support>
    <Secondary_Sponsor>Varian Medical Systems;Centro Diagnostico Milano, Co-PI: Pantaleo Romanelli, MD
    </Secondary_Sponsor>
    
  </Trial>

    
  <Trial><Export_date>03/02/2024 23:52:17</Export_date>
    <Internal_Number>11613912
    </Internal_Number>
    <TrialID>NCT04748640
    </TrialID>
    <Last_Refreshed_on>22 November 2021
    </Last_Refreshed_on>
    <Public_title>Bilateral Essential Tremor Treatment With Gamma Knife
    </Public_title>
    <Scientific_title>Bilateral Essential Tremor Treatment With Gamma Knife
    </Scientific_title>
    <Acronym>BEST-GK
    </Acronym>
    <Primary_sponsor>Universit√© de Sherbrooke
    </Primary_sponsor>
    <Retrospective_flag>Yes
    </Retrospective_flag>
    <Date_registration3>20210205
    </Date_registration3>
    <Date_registration>05/02/2021
    </Date_registration>
    <Source_Register>ClinicalTrials.gov
    </Source_Register>
    <web_address>https://clinicaltrials.gov/show/NCT04748640
    </web_address>
    <Recruitment_Status>Recruiting
    </Recruitment_Status>
    <other_records>No
    </other_records>
    <Inclusion_agemin>18 Years
    </Inclusion_agemin>
    <Inclusion_agemax>N/A
    </Inclusion_agemax>
    <Inclusion_gender>All
    </Inclusion_gender>
    <Date_enrollement>June 8, 2021
    </Date_enrollement>
    <Target_size>50
    </Target_size>
    <Study_type>Interventional
    </Study_type>
    <Study_design>Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label). 
    </Study_design>
    <Phase>Phase 2/Phase 3
    </Phase>
    <Countries>Canada
    </Countries>
    <Contact_Firstname>&#x20;
    </Contact_Firstname>
    <Contact_Lastname>Christian Iorio-Morin
    </Contact_Lastname>
    <Contact_Email>christian.iorio-morin@usherbrooke.ca
    </Contact_Email>
    <Contact_Tel>819-346-1110
    </Contact_Tel>
    <Contact_Affiliation/>
    <Inclusion_Criteria>&#x0D;&lt;br&gt;        Inclusion Criteria:&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Patients must be = 18 years&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  The patient has a primary diagnosis of ET or ET plus confirmed by a movement disorder&#x0D;&lt;br&gt;             neurologist;&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  The patient previously underwent a GK thalamotomy (&gt; 12 months ago);&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  The tremor on the untreated side negatively impacts the patients' quality of life;&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  The patient wants treatment of the contralateral side.&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;        Exclusion Criteria:&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Clinically relevant gait and/or balance impairment (e.g. wide-based, more than 2&#x0D;&lt;br&gt;             falls/months, wheelchair, walker, cane use);&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Clinically relevant speech impairment (e.g. impairment of intelligibility);&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Inability to comply with the follow-up schedule;&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Refusal of the treating physician.&#x0D;&lt;br&gt;      
    </Inclusion_Criteria>
    <Condition>Essential Tremor
    </Condition>
    <Intervention>Procedure: Gamma Knife VIM thalamotomy
    </Intervention>
    <Primary_outcome>Change in QUEST Score;Patient-based Assessment of Utility
    </Primary_outcome>
    <Secondary_outcome>Gait Assessment (NRS-11);Gait Assessment (missteps);Falls;Speech Assessment (NRS-11);Numbness;Dysgeusia;Other adverse events;Tremor (CRST);Quality of life (QUEST);Quality of life (CRST part C);Health Utility (EQ-5D-5L)
    </Secondary_outcome>
    <Secondary_ID>20-5172
    </Secondary_ID>
    <Source_Support>Please refer to primary and secondary sponsors
    </Source_Support>
    <Secondary_Sponsor>University Health Network, Toronto
    </Secondary_Sponsor>
    
  </Trial>

    
  <Trial><Export_date>03/02/2024 23:52:17</Export_date>
    <Internal_Number>6696394
    </Internal_Number>
    <TrialID>NCT03350139
    </TrialID>
    <Last_Refreshed_on>16 December 2017
    </Last_Refreshed_on>
    <Public_title>Evaluation of the Predictors of Clinical and Radiological Response to Gamma-Knife Radiosurgery in the Treatment of Intermediate Ventral Nucleus of the Thalamus (VIM) Thalamotomy Tremor.
    </Public_title>
    <Scientific_title>Evaluation of the Predictors of Clinical and Radiological Response to Gamma-Knife Radiosurgery in the Treatment of Intermediate Ventral Nucleus of the Thalamus (VIM) Thalamotomy Tremor.
    </Scientific_title>
    <Acronym>GARP
    </Acronym>
    <Primary_sponsor>Assistance Publique Hopitaux De Marseille
    </Primary_sponsor>
    <Retrospective_flag>No
    </Retrospective_flag>
    <Date_registration3>20171116
    </Date_registration3>
    <Date_registration>16/11/2017
    </Date_registration>
    <Source_Register>ClinicalTrials.gov
    </Source_Register>
    <web_address>https://clinicaltrials.gov/show/NCT03350139
    </web_address>
    <Recruitment_Status>Recruiting
    </Recruitment_Status>
    <other_records>No
    </other_records>
    <Inclusion_agemin>20 Years
    </Inclusion_agemin>
    <Inclusion_agemax>N/A
    </Inclusion_agemax>
    <Inclusion_gender>All
    </Inclusion_gender>
    <Date_enrollement>October 23, 2017
    </Date_enrollement>
    <Target_size>700
    </Target_size>
    <Study_type>Observational
    </Study_type>
    <Study_design/>
    <Phase>N/A
    </Phase>
    <Countries>France;France;France;France;France
    </Countries>
    <Contact_Firstname> ; ; ; ; ; ; ; ; ; ; ; ; ; ; 
    </Contact_Firstname>
    <Contact_Lastname>Jean-Olivier ARNAUD, General Director;Jean REGIS, PU-PH;Jean REGIS, PU-PH;Jean-Olivier ARNAUD, General Director;Jean REGIS, PU-PH;Jean REGIS, PU-PH;Jean-Olivier ARNAUD, General Director;Jean REGIS, PU-PH;Jean REGIS, PU-PH;Jean-Olivier ARNAUD, General Director;Jean REGIS, PU-PH;Jean REGIS, PU-PH;Jean-Olivier ARNAUD, General Director;Jean REGIS, PU-PH;Jean REGIS, PU-PH
    </Contact_Lastname>
    <Contact_Email>;jregis@ap-hm.fr;jregis@ap-hm.fr;;jregis@ap-hm.fr;jregis@ap-hm.fr;;jregis@ap-hm.fr;jregis@ap-hm.fr;;jregis@ap-hm.fr;jregis@ap-hm.fr;;jregis@ap-hm.fr;jregis@ap-hm.fr
    </Contact_Email>
    <Contact_Tel>;491387058;491387056;;491387058;491387056;;491387058;491387056;;491387058;491387056;;491387058;491387056
    </Contact_Tel>
    <Contact_Affiliation>Assistance Publique H√¥pitaux de Marseille;;Assistance Publique H√¥pitaux de Marseille;;Assistance Publique H√¥pitaux de Marseille;;Assistance Publique H√¥pitaux de Marseille;;Assistance Publique H√¥pitaux de Marseille;
    </Contact_Affiliation>
    <Inclusion_Criteria>&#x0D;&lt;br&gt;        Inclusion Criteria:&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Male or female aged 20 years minimum&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Patient with absolute contraindication or relative to deep brain stimulation (DBS) of&#x0D;&lt;br&gt;             VIM.&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Patient having the Gamma Knife radiosurgery of VIM (combining clinical and&#x0D;&lt;br&gt;             paraclinical conditions).&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Patient affiliated to a social security scheme.&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Patient having understood and signed the information notice for non opposition.&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;        Exclusion Criteria:&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Patient having a contraindication to performing a cerebral MRI (pace-maker,&#x0D;&lt;br&gt;             intracerebral metallic object etc.)&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Patient with a contraindication to radiosurgical treatment (previous treatment with&#x0D;&lt;br&gt;             cerebral radiotherapy)&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Vulnerable persons: minors, protected adults (guardianship or trusteeship) and adults&#x0D;&lt;br&gt;             unable to express their non-opposition.&#x0D;&lt;br&gt;      ;&#x0D;&lt;br&gt;        Inclusion Criteria:&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Male or female aged 20 years minimum&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Patient with absolute contraindication or relative to deep brain stimulation (DBS) of&#x0D;&lt;br&gt;             VIM.&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Patient having the Gamma Knife radiosurgery of VIM (combining clinical and&#x0D;&lt;br&gt;             paraclinical conditions).&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Patient affiliated to a social security scheme.&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Patient having understood and signed the information notice for non opposition.&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;        Exclusion Criteria:&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Patient having a contraindication to performing a cerebral MRI (pace-maker,&#x0D;&lt;br&gt;             intracerebral metallic object etc.)&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Patient with a contraindication to radiosurgical treatment (previous treatment with&#x0D;&lt;br&gt;             cerebral radiotherapy)&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Vulnerable persons: minors, protected adults (guardianship or trusteeship) and adults&#x0D;&lt;br&gt;             unable to express their non-opposition.&#x0D;&lt;br&gt;      ;&#x0D;&lt;br&gt;        Inclusion Criteria:&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Male or female aged 20 years minimum&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Patient with absolute contraindication or relative to deep brain stimulation (DBS) of&#x0D;&lt;br&gt;             VIM.&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Patient having the Gamma Knife radiosurgery of VIM (combining clinical and&#x0D;&lt;br&gt;             paraclinical conditions).&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Patient affiliated to a social security scheme.&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Patient having understood and signed the information notice for non opposition.&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;        Exclusion Criteria:&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Patient having a contraindication to performing a cerebral MRI (pace-maker,&#x0D;&lt;br&gt;             intracerebral metallic object etc.)&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Patient with a contraindication to radiosurgical treatment (previous treatment with&#x0D;&lt;br&gt;             cerebral radiotherapy)&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Vulnerable persons: minors, protected adults (guardianship or trusteeship) and adults&#x0D;&lt;br&gt;             unable to express their non-opposition.&#x0D;&lt;br&gt;      ;&#x0D;&lt;br&gt;        Inclusion Criteria:&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Male or female aged 20 years minimum&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Patient with absolute contraindication or relative to deep brain stimulation (DBS) of&#x0D;&lt;br&gt;             VIM.&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Patient having the Gamma Knife radiosurgery of VIM (combining clinical and&#x0D;&lt;br&gt;             paraclinical conditions).&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Patient affiliated to a social security scheme.&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Patient having understood and signed the information notice for non opposition.&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;        Exclusion Criteria:&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Patient having a contraindication to performing a cerebral MRI (pace-maker,&#x0D;&lt;br&gt;             intracerebral metallic object etc.)&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Patient with a contraindication to radiosurgical treatment (previous treatment with&#x0D;&lt;br&gt;             cerebral radiotherapy)&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Vulnerable persons: minors, protected adults (guardianship or trusteeship) and adults&#x0D;&lt;br&gt;             unable to express their non-opposition.&#x0D;&lt;br&gt;      
    </Inclusion_Criteria>
    <Condition>Severe Disabling Tremor;Severe Disabling Tremor;Severe Disabling Tremor;Severe Disabling Tremor
    </Condition>
    <Intervention>Device: gamma knife radiosurgery;Device: gamma knife radiosurgery;Device: gamma knife radiosurgery;Device: gamma knife radiosurgery
    </Intervention>
    <Primary_outcome>Clinical evaluation of tremor reduction in relation to clinical co-morbidity;Clinical evaluation of tremor reduction in relation to clinical co-morbidity;Clinical evaluation of tremor reduction in relation to clinical co-morbidity
    </Primary_outcome>
    <Secondary_ID>ID RCB;2017-09
    </Secondary_ID>
    <Source_Support>Please refer to primary and secondary sponsors
    </Source_Support>
    
  </Trial>

    
  <Trial><Export_date>03/02/2024 23:52:17</Export_date>
    <Internal_Number>12779567
    </Internal_Number>
    <TrialID>NCT02255929
    </TrialID>
    <Last_Refreshed_on>30 January 2023
    </Last_Refreshed_on>
    <Public_title>Gamma Knife Radiosurgery for Treatment of Essential Tremor
    </Public_title>
    <Scientific_title>Gamma Knife Thalamotomy for Treatment of Essential Tremor
    </Scientific_title>
    <Acronym/>
    <Primary_sponsor>Swedish Medical Center
    </Primary_sponsor>
    <Retrospective_flag>No
    </Retrospective_flag>
    <Date_registration3>20140917
    </Date_registration3>
    <Date_registration>17/09/2014
    </Date_registration>
    <Source_Register>ClinicalTrials.gov
    </Source_Register>
    <web_address>https://clinicaltrials.gov/show/NCT02255929
    </web_address>
    <Recruitment_Status>Not recruiting
    </Recruitment_Status>
    <other_records>No
    </other_records>
    <Inclusion_agemin>18 Years
    </Inclusion_agemin>
    <Inclusion_agemax>N/A
    </Inclusion_agemax>
    <Inclusion_gender>All
    </Inclusion_gender>
    <Date_enrollement>September 2014
    </Date_enrollement>
    <Target_size>183
    </Target_size>
    <Study_type>Interventional
    </Study_type>
    <Study_design>Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label). 
    </Study_design>
    <Phase>N/A
    </Phase>
    <Countries>United States
    </Countries>
    <Contact_Firstname>&#x20;
    </Contact_Firstname>
    <Contact_Lastname>Christopher Loiselle, MD
    </Contact_Lastname>
    <Contact_Email/>
    <Contact_Tel/>
    <Contact_Affiliation>Swedish Medical Center Radiosurgery Center
    </Contact_Affiliation>
    <Inclusion_Criteria>&#x0D;&lt;br&gt;        Inclusion Criteria:&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Men and women age 18 years or older&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Diagnosis of essential tremor as confirmed from clinical history and examination by a&#x0D;&lt;br&gt;             neurologist or neurosurgeon&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Tremor following prior first line therapy with either propranolol or primidone&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Must be able to undergo MRI of brain and CT of head for treatment planning&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Postural or intention tremor severity score of greater than or equal to 2 in one&#x0D;&lt;br&gt;             hand/arm as measured by the CRST rating scale&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;        Exclusion Criteria:&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Prior ipsilateral stereotactic radiosurgical ablation of the thalamus, ipsilateral&#x0D;&lt;br&gt;             deep brain stimulation, radiofrequency ablation of a ipsilateral thalamic target, or&#x0D;&lt;br&gt;             ultrasound ablation of an ipsilateral thalamic target&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Prior whole brain radiation therapy&#x0D;&lt;br&gt;&#x0D;&lt;br&gt;          -  Pregnancy&#x0D;&lt;br&gt;      
    </Inclusion_Criteria>
    <Condition>Essential Tremor
    </Condition>
    <Intervention>Radiation: Gamma Knife Radiosurgery
    </Intervention>
    <Primary_outcome>Change in Effectiveness based on Clinical Rating Scale for Tumor (CRST-Part B) questionnaires.
    </Primary_outcome>
    <Secondary_outcome>Safety Based on the Number of Incidences and Severity of Adverse Events Related with Gamma Knife Thalamotomy
    </Secondary_outcome>
    <Secondary_ID>IR 5585
    </Secondary_ID>
    <Source_Support>Please refer to primary and secondary sponsors
    </Source_Support>
    
  </Trial>
</Trials_downloaded_from_ICTRP>